Sai Life Sciences Ltd
Company Profile
Business description
Sai Life Sciences Ltd is an innovator-focused, contract research, development, and manufacturing organization. It provides end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (NCE), to pharmaceutical innovator companies and biotechnology firms. It possesses both; discovery/contract research (CRO) and chemistry, manufacturing, and control (CMC)/contract development and manufacturing organization (CDMO) capabilities. The company has only one reportable segment: contract research, development, and manufacturing. Geographically it operates in India as well as Outside India.
Contact
Gachibowli Miyapur Road
L4- 01 & 02, SLN Terminus Survey, Survey no. 133
Gachibowli
HyderabadTG500032
INDT: +91 4068156000
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 March 2026
Employees
3,401
Stocks News & Analysis
stocks
Anglo American strikes deal to create a new copper giant
stocks
The ‘other’ AI chip behemoth that might just be getting started
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,071.40 | 9.10 | -0.10% |
CAC 40 | 7,820.09 | 58.77 | 0.76% |
DAX 40 | 23,649.45 | 16.50 | 0.07% |
Dow JONES (US) | 45,490.92 | 220.42 | -0.48% |
FTSE 100 | 9,263.51 | 38.12 | 0.41% |
HKSE | 26,086.32 | 113.94 | -0.43% |
NASDAQ | 21,886.06 | 6.57 | 0.03% |
Nikkei 225 | 44,372.50 | 534.83 | 1.22% |
NZX 50 Index | 13,229.15 | 47.09 | -0.35% |
S&P 500 | 6,532.04 | 19.43 | 0.30% |
S&P/ASX 200 | 8,805.00 | 8.80 | -0.10% |
SSE Composite Index | 3,875.31 | 63.09 | 1.65% |